These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 9052917
1. Late onset haemolysis and red cell autoimmunisation after allogeneic bone marrow transplant. Chen FE, Owen I, Savage D, Roberts I, Apperley J, Goldman JM, Laffan M. Bone Marrow Transplant; 1997 Mar; 19(5):491-5. PubMed ID: 9052917 [Abstract] [Full Text] [Related]
2. Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation. Drobyski WR, Potluri J, Sauer D, Gottschall JL. Bone Marrow Transplant; 1996 Jun; 17(6):1093-9. PubMed ID: 8807120 [Abstract] [Full Text] [Related]
4. Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia. De Lord C, Marsh JC, Smith JG, Singer CR, Gordon-Smith EC. Bone Marrow Transplant; 1996 Jul; 18(1):237-9. PubMed ID: 8832026 [Abstract] [Full Text] [Related]
6. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, Patriarca F, de Vita S, Regazzi M, Baccarani M, Fanin R. Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170 [Abstract] [Full Text] [Related]
10. Evans syndrome after autologous bone marrow transplant for recurrent Hodgkin's disease. Keung YK, Cobos E, Bolanos-Meade J, Issarachai S, Brideau A, Morgan D. Bone Marrow Transplant; 1997 Dec; 20(12):1099-101. PubMed ID: 9466285 [Abstract] [Full Text] [Related]
14. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Keever-Taylor CA, Bredeson C, Loberiza FR, Casper JT, Lawton C, Rizzo D, Burns WH, Margolis DA, Vesole DH, Horowitz M, Zhang MJ, Juckett M, Drobyski WR. Biol Blood Marrow Transplant; 2001 Dec; 7(11):620-30. PubMed ID: 11760150 [Abstract] [Full Text] [Related]
15. Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study. Joshi SS, Bishop MR, Lynch JC, Tarantolo SR, Abhyankar S, Bierman PJ, Vose JM, Geller RB, McGuirk J, Foran J, Bociek RG, Hadi A, Day SD, Armitage JO, Kessinger A, Pavletic ZS. Cytotherapy; 2003 Dec; 5(6):542-52. PubMed ID: 14660050 [Abstract] [Full Text] [Related]
17. Impact of AB0-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Kimura F, Sato K, Kobayashi S, Ikeda T, Sao H, Okamoto S, Miyamura K, Mori S, Akiyama H, Hirokawa M, Ohto H, Ashida H, Motoyoshi K, Japan Marrow Donor Program. Haematologica; 2008 Nov; 93(11):1686-93. PubMed ID: 18835834 [Abstract] [Full Text] [Related]
19. Antibody to blood group glycosyltransferases in a patient transplanted with an ABO incompatible bone marrow. Kominato Y, Fujikura T, Takizawa H, Hayashi K, Mori T, Matsue K, Yasue S, Matsuda T. Exp Clin Immunogenet; 1990 Nov; 7(2):85-90. PubMed ID: 2108709 [Abstract] [Full Text] [Related]